Investor Presentaiton slide image

Investor Presentaiton

OPERATING PERFORMANCE HOSPITAL BUSINESS Particulars (INR Cr) Hospital Business Operating Revenue Revenue Growth vs LY Q3FY23 Q2FY24 Q3FY24 9MFY23 9MFY24 1,267.4 1,452.6 1,389.5 3,756.8 4,196.2 12.0% 9.6% 11.7% Reported EBITDA^ 217.0 289.4 253.6 692.0 751.1 EBITDA growth vs LY 8.3% 16.9% 8.5% Margin 17.1% 19.9% 18.2% 18.4% 17.9% Adj: Other Income^ 6.0 21.7 2.8 51.0 26.2 Operating EBITDA 211.0 267.7 250.8 641.0 724.9 Margin 16.7% 18.4% 18.0% 17.1% 17.3% • Above financials includes financials of International entities which are part of Fortis group; mainly RHTTM ^Hospital business reported EBITDA for Q2FY24, 9MFY24 and 9MFY23 includes other income primarily as a result of the dividend income received from the Company's majority owed (57%) subsidiary Agilus Diagnostics Fortis 14
View entire presentation